Coping With HIV/AIDS in Tanzania

坦桑尼亚应对艾滋病毒/艾滋病

• 批准号: 7667262
• 负责人: KATHRYN WHETTEN
• 金额: $ 52.37万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-06 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7667262
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Address; Adherence; Adult; Adverse effects; Africa South of the Sahara; Aftercare; Age; Antiretroviral drug resistance; Anxiety; Appointment; Area; Bed Occupancy; Belief; CD4 Lymphocyte Count; Caregivers; Caring; Case Manager; Characteristics; Child Care; Clinic; Clinical Data; Cohort Studies; Communicable Diseases; Counseling; Country; Cross-Sectional Studies; Data; Data Analyses; Data Collection; Deltastab; Diagnosis; Disease; Disease Progression; Economic Factors; Economics; Education; Emergency Situation; Enrollment; Ensure; Ethnic Origin; Event; Funding; Future; Gender; HIV; HIV Infections; HIV Seropositivity; HIV diagnosis; Health; Health Promotion; Health Status; Health behavior; Healthcare; Home environment; Housing; Human immunodeficiency virus test; Income; Individual; International; International AIDS; Intervention; Interview; Knowledge; Laboratories; Lead; Life; Life Experience; Link; Location; Malaria; Mediator of activation protein; Medical; Medical center; Mental Health; Modeling; Morbidity - disease rate; Newly Diagnosed; Orphan; Outcome; Participant; Patients; Peer Review; Persons; Pharmaceutical Preparations; Physicians; Play; Policies; Population Study; Predisposition; Prevention; Prevention education; Protocols documentation; Provider; Psychosocial Factor; Public Health; Quality of life; Recruitment Activity; Reporting; Research; Research Personnel; Resistance; Resources; Respondent; Risk; Risk Behaviors; Risk Reduction; Role; Rural; Sampling; Self Efficacy; Series; Services; Severities; Site; Social support; Socioeconomic Status; Stigmata; Stress; Symptoms; System; Tanzania; Testing; Time; Time Study; Transportation; Trauma; Treatment Efficacy; Treatment Protocols; Treatment outcome; Trust; Tuberculosis; Universities; Viral Load result; Virus; Woman; Work; antiretroviral therapy; base; care seeking; cohort; coping; cost; demographics; depression; design; diaries; ethnic minority population; fighting; health care service utilization; health related quality of life; high risk; high risk sexual behavior; improved; interest; medication compliance; mortality; patient population; physical abuse; pill; programs; psychological distress; psychosocial; research study; residence; scale up; service utilization; social stigma; symposium; tertiary care; treatment adherence; urban area; viral resistance

DESCRIPTION (provided by applicant): Two-thirds of the >38 million people with HIV/AIDS reside in Sub-Saharan Africa. Access to antiretroviral therapy (ART) in less wealthy nations is expanding quickly, creating an urgent need to understand those factors influencing adherence, a key determinant of ongoing efficacy of ART, so that the creation and spread of medication-resistant virus is limited. The proposed research team has identified suboptimal adherence among 29% of clinic attendees taking ART for > 6 months in Moshi Tanzania, while documenting lack of virologic suppression in 32% and antiretroviral drug resistance in 10%. We propose to follow 750 newly diagnosed HIV+ persons, 500 previously diagnosed HIV+ persons and 750 HIV-negative persons in over 3 years in this region. The newly diagnosed HIV+ and HIV- cohorts will be obtained through consecutive sampling in a Voluntary Counseling and Testing (VCT) site and the on-going HIV+ cohort will be similarly drawn from the Infectious Disease Clinic (IDC) in the tertiary care medical center 5 miles away. This research team has a track record of successful past and ongoing research at both the VCT and the IDC sites. Baseline data we will used to examine associations between psychosocial (including trauma, mental health symptomatology, coping strategies and life events), sociodemographic, and economic factors and health status, adherence to ART, and health promotion and high risk activities. Longitudinal analyses will examine causal relationships between changes in the independent and dependent variables. Results will lead to the creation of more effective prevention and care models for the area and other similar areas. Studying the population of ART naive patients in a resource poor setting provides a unique window of opportunity to gather data designed to increase our understanding of underlying variables associated with maladherence and risk behaviors. Psychosocial determinants are a unique strength of this proposal. The study will result in a minimum of 7 peer reviewed articles and dissemination of findings at annual national (US and Tanzanian) and international AIDS, Public Health and Mental Health conferences, including the annual Tanzania national AIDS conference. A policy related report will be disseminated to national and international leaders.

描述(由申请人提供)：在3800万艾滋病毒/艾滋病患者中，三分之二居住在撒哈拉以南非洲。在不太富裕的国家，获得抗逆转录病毒疗法(ART)的机会正在迅速扩大，因此迫切需要了解那些影响依从性的因素，这是ART持续疗效的关键决定因素，以便限制耐药病毒的产生和传播。拟议的研究小组发现，在坦桑尼亚摩西接受抗逆转录病毒治疗6个月的患者中，29%的患者依从性不佳，同时有32%的患者缺乏病毒学抑制，10%的患者对抗逆转录病毒药物产生抗药性。我们建议在3年多的时间里对该地区750名新诊断的HIV阳性患者、500名既往诊断的HIV阳性患者和750名HIV阴性患者进行跟踪调查。新诊断的HIV+和HIV-队列将通过在自愿咨询和检测(VCT)站点连续抽样获得，正在进行的HIV+队列将同样从5英里外三级保健医疗中心的传染病诊所(IDC)抽取。这个研究团队在VCT和IDC站点都有成功的过去和正在进行的研究的跟踪记录。我们将使用基线数据来检查心理社会(包括创伤、心理健康症状学、应对策略和生活事件)、社会人口和经济因素与健康状况、对抗逆转录病毒治疗的坚持、健康促进和高风险活动之间的关系。纵向分析将检验自变量和因变量变化之间的因果关系。结果将导致为该地区和其他类似地区建立更有效的预防和护理模式。在资源匮乏的情况下研究未接受抗逆转录病毒治疗的患者群体，为收集数据提供了一个独特的机会之窗，旨在增加我们对与违规和危险行为相关的潜在变量的理解。心理社会决定因素是这一提议的独特优势。这项研究将产生至少7篇同行评议的文章，并在年度全国(美国和坦桑尼亚)和国际艾滋病、公共卫生和精神卫生会议上传播研究结果，包括坦桑尼亚年度全国艾滋病会议。一份与政策有关的报告将分发给国家和国际领导人。